EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.2.2.29 | Adenocarcinoma |
10360221 |
Genomic analysis of the thymine-DNA glycosylase (TDG) gene on 12q22-q24.1 in human pancreatic ductal adenocarcinoma. |
causal interaction
ongoing research
unassigned |
2
3
0 |
| 3.2.2.29 | Breast Neoplasms |
26171207 |
miR-29b is an indicator of prognosis in breast cancer patients. |
causal interaction
diagnostic usage
unassigned |
2
3
0 |
| 3.2.2.29 | Breast Neoplasms |
29378668 |
Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization. |
ongoing research
unassigned |
1
0 |
| 3.2.2.29 | Carcinogenesis |
9794235 |
Expression of T:G mismatch-specific thymidine-DNA glycosylase and DNA methyl transferase genes during development and tumorigenesis. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
4
1
0 |
| 3.2.2.29 | Carcinogenesis |
10360221 |
Genomic analysis of the thymine-DNA glycosylase (TDG) gene on 12q22-q24.1 in human pancreatic ductal adenocarcinoma. |
causal interaction
ongoing research
unassigned |
2
3
0 |
| 3.2.2.29 | Carcinogenesis |
26370152 |
Multifaceted roles for thymine DNA glycosylase in embryonic development and human carcinogenesis. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 3.2.2.29 | Carcinoma, Hepatocellular |
32268085 |
Loss of Thymine DNA Glycosylase Causes Dysregulation of Bile Acid Homeostasis and Hepatocellular Carcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
2
0 |
| 3.2.2.29 | Carcinoma, Hepatocellular |
32944627 |
TDG is a novel tumor suppressor of liver malignancies. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.2.2.29 | Colorectal Neoplasms |
24532795 |
Thymine DNA glycosylase is a positive regulator of wnt signaling in colorectal cancer. |
causal interaction
diagnostic usage
unassigned |
3
2
0 |
| 3.2.2.29 | Ependymoma |
28228863 |
Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated TET1 expression. |
unassigned |
0 |
